Xtant Financial Statements From 2010 to 2024

XTNT Stock  USD 0.78  0.01  1.27%   
Xtant Medical financial statements provide useful quarterly and yearly information to potential Xtant Medical Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Xtant Medical financial statements helps investors assess Xtant Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Xtant Medical's valuation are summarized below:
Gross Profit
32.1 M
Profit Margin
0.0072
Market Capitalization
112 M
Enterprise Value Revenue
1.3895
Revenue
91.3 M
There are currently one hundred twenty fundamental gauges for Xtant Medical Holdings that can be evaluated and compared over time across peers. All traders should confirm Xtant Medical's prevalent fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 141.3 M in 2024, whereas Enterprise Value is likely to drop slightly above 107.5 M in 2024.

Xtant Medical Total Revenue

53.73 Million

Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many exotic indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0034 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
This module can also supplement various Xtant Medical Technical models . Check out the analysis of Xtant Medical Correlation against competitors.

Xtant Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets60 M92.6 M60.4 M
Slightly volatile
Other Current Liabilities10.9 M10.4 M3.5 M
Slightly volatile
Total Current Liabilities16 M23 M15.2 M
Slightly volatile
Accounts Payable4.9 M7.1 M4.8 M
Pretty Stable
Cash5.8 M5.9 MM
Slightly volatile
Cash And Short Term Investments5.8 M5.9 MM
Slightly volatile
Net Receivables21.8 M20.7 M10.5 M
Slightly volatile
Common Stock Shares Outstanding133.1 M126.8 M33.2 M
Slightly volatile
Liabilities And Stockholders Equity60 M92.6 M60.4 M
Slightly volatile
Inventory38.7 M36.9 M18.6 M
Slightly volatile
Other Stockholder Equity309 M294.3 M151.2 M
Slightly volatile
Total Liabilities60.8 M41.3 M61.5 M
Very volatile
Total Current Assets33.6 M64.9 M33.7 M
Slightly volatile
Short and Long Term Debt Total22.4 M23.6 M46.9 M
Very volatile
Property Plant And Equipment Net7.8 M10.2 M7.4 M
Slightly volatile
Current Deferred Revenue6.5 M7.6 M6.3 M
Slightly volatile
Non Current Assets Total28.2 M27.7 M27.1 M
Very volatile
Non Currrent Assets Other133.9 K141 K1.4 M
Slightly volatile
Common Stock Total Equity1.711.812.834
Slightly volatile
Non Current Liabilities Total17.4 M18.3 M44.5 M
Very volatile
Property Plant And Equipment Gross31.4 M29.9 M10.2 M
Slightly volatile
Short Term Debt3.7 M5.5 M3.6 M
Slightly volatile
Intangible Assets7.8 M10.1 M7.5 M
Very volatile
Common Stock1.711.850.1007
Slightly volatile
Other Assets0.951.01.3 M
Slightly volatile
Long Term Debt16.3 M17.2 M43.3 M
Very volatile
Property Plant Equipment7.6 M6.7 MM
Pretty Stable
Other Liabilities5.3 M5.7 M6.4 M
Slightly volatile
Short and Long Term Debt4.4 M4.6 M21.9 M
Very volatile
Long Term Debt Total8.3 M8.7 M74.9 M
Slightly volatile
Capital Surpluse177 M319.5 M154 M
Slightly volatile
Capital Lease Obligations1.6 M1.8 M1.3 M
Slightly volatile
Net Invested Capital54.3 M73.1 M63.7 M
Slightly volatile
Net Working Capital27.4 M41.9 M19.8 M
Slightly volatile

Xtant Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue53.7 M91.3 M54.2 M
Slightly volatile
Gross Profit34 M55.5 M34.1 M
Slightly volatile
Other Operating Expenses60.4 M101.5 M60.3 M
Slightly volatile
Cost Of Revenue19.8 M35.8 M20.1 M
Slightly volatile
Total Operating Expenses40.7 M65.6 M40.2 M
Slightly volatile
Depreciation And Amortization3.1 M3.2 MM
Pretty Stable
Selling General Administrative14.3 M25.9 M13.3 M
Slightly volatile
Selling And Marketing Expenses27.5 M38.4 M25.2 M
Slightly volatile
Non Recurring61.7 M58.8 M27.3 M
Slightly volatile
Reconciled Depreciation2.9 M2.5 M5.8 M
Slightly volatile

Xtant Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow21.5 M20.5 M6.7 M
Slightly volatile
End Period Cash Flow5.8 M5.9 MM
Slightly volatile
Stock Based Compensation1.4 M2.7 M1.3 M
Slightly volatile
Depreciation3.1 M3.2 MM
Pretty Stable
Cash Flows Other Operating425.8 K448.2 K5.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.41.473915.7056
Slightly volatile
Dividend Yield0.00340.00380.0041
Slightly volatile
Days Sales Outstanding73.4382.875964.3521
Very volatile
Average Payables9.4 M8.9 M7.3 M
Slightly volatile
Stock Based Compensation To Revenue0.0370.030.0338
Slightly volatile
EV To Sales1.581.667116.3008
Slightly volatile
Inventory Turnover0.920.97162.0801
Slightly volatile
Days Of Inventory On Hand382376304
Pretty Stable
Payables Turnover3.865.08025.2138
Slightly volatile
Sales General And Administrative To Revenue0.320.28310.2904
Slightly volatile
Average Inventory11.6 M17.8 M17.3 M
Slightly volatile
Research And Ddevelopement To Revenue0.02730.01460.0292
Slightly volatile
Cash Per Share0.04720.04972.9155
Slightly volatile
Days Payables Outstanding12071.84788.8401
Slightly volatile
Intangibles To Total Assets0.130.18770.1684
Very volatile
Current Ratio1.732.82162.289
Slightly volatile
Receivables Turnover4.694.40426.0059
Very volatile
Graham Number0.220.231937.6007
Slightly volatile
Average Receivables4.5 M8.9 M7.8 M
Slightly volatile
Revenue Per Share0.730.766635.9427
Slightly volatile
Interest Debt Per Share0.20.215138.9346
Slightly volatile
Debt To Assets0.230.24490.7018
Very volatile
Operating Cycle456459369
Pretty Stable
Days Of Payables Outstanding12071.84788.8401
Slightly volatile
Ebt Per Ebit0.0970.10211.8749
Very volatile
Long Term Debt To Capitalization0.240.25060.9149
Pretty Stable
Total Debt To Capitalization0.290.30640.9884
Pretty Stable
Quick Ratio0.831.15941.1198
Slightly volatile
Cash Ratio0.340.25760.4733
Slightly volatile
Cash Conversion Cycle336387280
Slightly volatile
Days Of Inventory Outstanding382376304
Pretty Stable
Days Of Sales Outstanding73.4382.875964.3521
Very volatile
Fixed Asset Turnover5.778.93817.2891
Slightly volatile
Debt Ratio0.230.24490.7018
Very volatile
Price Sales Ratio1.41.473915.7056
Slightly volatile
Asset Turnover1.290.98591.2242
Slightly volatile
Gross Profit Margin0.490.60750.5898
Pretty Stable

Xtant Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap141.3 M134.6 M54 M
Pretty Stable
Enterprise Value107.5 M152.2 M92.4 M
Very volatile

Xtant Fundamental Market Drivers

Cash And Short Term Investments5.9 M

Xtant Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Xtant Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Xtant Medical income statement, its balance sheet, and the statement of cash flows. Xtant Medical investors use historical funamental indicators, such as Xtant Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may use each financial statement separately, they are all related. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Xtant Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Xtant Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Xtant Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue7.6 M6.5 M
Total Revenue91.3 M53.7 M
Cost Of Revenue35.8 M19.8 M
Stock Based Compensation To Revenue 0.03  0.04 
Sales General And Administrative To Revenue 0.28  0.32 
Research And Ddevelopement To Revenue 0.01  0.03 
Capex To Revenue(0.02)(0.02)
Revenue Per Share 0.77  0.73 
Ebit Per Revenue(0.11)(0.12)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Xtant Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Xtant Medical's short interest history, or implied volatility extrapolated from Xtant Medical options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Xtant Medical Holdings is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Xtant Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Xtant Medical Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Xtant Medical Holdings Stock:
Check out the analysis of Xtant Medical Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Xtant Stock analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Xtant Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xtant Medical. If investors know Xtant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xtant Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.01
Revenue Per Share
0.767
Quarterly Revenue Growth
0.841
Return On Assets
(0.08)
Return On Equity
0.0154
The market value of Xtant Medical Holdings is measured differently than its book value, which is the value of Xtant that is recorded on the company's balance sheet. Investors also form their own opinion of Xtant Medical's value that differs from its market value or its book value, called intrinsic value, which is Xtant Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xtant Medical's market value can be influenced by many factors that don't directly affect Xtant Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xtant Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xtant Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xtant Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.